Business Description
GNI Group Ltd. is a pharmaceutical and medical equipment company founded in 2001 and based in Chuo, Japan, with operations across Japan, China, and the United States. The company sells approved treatments for conditions such as pulmonary fibrosis, bone defects, and wounds, while running an extensive pipeline of drug candidates targeting liver disease, lung injury, pain, and cancer. Several of these candidates are currently in Phase I through Phase III clinical trials, reflecting the company's strong focus on bringing new medicines to market.
